Why the study?
Does 18F-FDG uptake on oncologic PET/CT correlate with specific echocardiographic findings in patients undergoing oncology imaging?
Does 18F-FDG uptake on oncologic PET/CT correlate with specific echocardiographic findings in patients undergoing oncology imaging?
Cardiac and pericardial 18F-FDG uptake on oncologic PET/CT correlates with specific echocardiographic abnormalities depending on the site of uptake.
Answers are grounded in this paper and cite their sources.
Cardiac FDG uptake on oncologic PET/CT may flag specific echo abnormalities; hypothesis-generating and leaves open prospective validation before clinical use.
BACKGROUND: F-FDG uptake on whole-body oncology PET/CT. METHODS: ) of all lesions was measured. RESULTS: than those without. Myocardial FDG uptake demonstrated pericardial effusion (57.1%), regional wall motion abnormality (57.1%), and increased myocardial wall thickness (42.9%). All cardiac chamber FDG uptakes showed intracardiac mass on TTE. CONCLUSIONS: F-FDG uptake on oncology PET/CT shows characteristic echocardiographic features according to which heart sites are involved.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: